Sacituzumab govitecanSacituzumab govitecan, sold under the brand name Trodelvy by Gilead Sciences, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer, previously treated metastatic hormone receptor–positive, HER2-negative breast cancer, and… Read from the Drugbox of the Wikipedia article Sacituzumab govitecan, revision 1370568880.

Property

Value

Formula

C76H104N12O24S, 1601.79 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.